Sanofi loses appeal on Taxotere patent; Third proxy firm backs Illumina over Roche;

@FiercePharma: WSJ previews Q1 earnings. Gist: Patent cliff rules. Pfizer's 1st full Q with Lipitor rivals, Lilly's with Zyprexa. More | Follow @FiercePharma

> Sanofi ($SNY) lost its bid to overturn a 2010 ruling that invalidated two U.S. patents on Taxotere; the cancer drug already faces generic rivals in the U.S. and Europe. Report

> Glass, Lewis & Co. became the third proxy firm to advise Illumina ($ILMN) shareholders against Roche's ($RHHBY.PK) nominees to the board, part of its move to take over the gene-sequencing company. Story

> European Medicines Agency officials are calling for open access to clinical trial data, in light of concerns about data on Roche's flu-fighting drug Tamiflu. Item

> Pfizer ($PFE) has to fight some liability claims related to its bankrupt Quigley unit, which produced asbestos-containing products from the 1940s to the 1970s. Article

> Indian government efforts to hold drugmakers to a marketing code have faltered, the India Times says. News

> Health products distributor Henry Schein has snapped up a European veterinary products distributor to gain access to animal health markets in Belgium and the Netherlands. Piece

Biotech News

@FierceBiotech: 'Hitchhiking' gold nanostars can sneak into cancer cells. More | Follow @FierceBiotech

@JohnCFierce: With Lipitor and Plavix out of the top 10, Abbott's Humira will take the top spot among best-sellers. Article | Follow @JohnCFierce

@RyanMFierce: An Arkansas jury rules against $JNJ in Risperdal marketing case, state AG says J&J 'lied.' Story  | Follow @RyanMFierce

> Threshold Pharma lands $20M milestone from Merck KGaA. News

> RNAi developer Arrowhead snags startup Alvos in stock deal. More

Medical Devices News

 @FierceMedDev: Tough luck, St. Jude: No retraction for you. News | Follow @FierceMedDev

> Ex-Orthofix VP pleads guilty over kickback. Article

> Report: Diabetes Dx market to hit $32B by 2017. More

Drug Delivery News

> Bind touts positive results for cancer-fighting nanoparticles. Article

> Natural mucoadhesive tablet delivers anti-cancer spice. Story

> Liquidia CEO: Nanotech will outpace biotech. More

> Is reformulation discouraging innovation? Piece

Biomarkers News

> Genomic sequencing--is it of value? Commentary

> Lung metastasis may be marked by tumor cell protein. More

> Scientists seek breast cancer biomarkers in a drop of blood. Article

> ARISk launched to screen for sibling autism risk. News

> Proteome Sciences shares jump on licensing deal. Item

And Finally... Fish-oil supplements may not prevent heart attacks and strokes in people who already have heart disease, a study finds. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.